Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport(®)) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity?

Intradetrusor injections of Botulinum toxin A—currently onabotulinumtoxinA—is registered as a second-line treatment to treat neurogenic detrusor overactivity (NDO). The common clinical practice is 30 × 1 mL injections in the detrusor; however, protocols remain variable and standardization is warrant...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Toxins (Basel)
Main Authors: Huynh Le Maux, Amélie, Pignol, Bernadette, Behr-Roussel, Delphine, Blachon, Jean-Luc, Chabrier, Pierre-Etienne, Compagnie, Sandrine, Picaut, Philippe, Bernabé, Jacques, Giuliano, François, Denys, Pierre
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4690145/
https://ncbi.nlm.nih.gov/pubmed/26694464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/toxins7124896
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados